A pilot phase II trial of magnesium supplements to reduce menopausal hot flashes in breast cancer patients

Supportive Care in Cancer

Volumn 19, Issue 6, 2011, Pages 859-863

  Park, Haeseong ^a   Parker, Gwendolyn L ^a   Boardman, Cecelia H ^b   Morris, Monica M ^c   Smith, Thomas J ^a,d  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d Thomas Palliative Care Unit   (United States)

Author keywords

Breast cancer; Drug treatment; Hot flashes; Menopause; Survivorship

Indexed keywords

ANTIDEPRESSANT AGENT; AROMATASE INHIBITOR; MAGNESIUM OXIDE; TAMOXIFEN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BEDTIME DOSAGE; BREAST CANCER; CANCER PATIENT; CAUCASIAN; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DISTRESS SYNDROME; DRUG COST; DRUG DOSE ESCALATION; DRUG RESPONSE; DRUG WITHDRAWAL; FATIGUE; FEMALE; HEADACHE; HOT FLUSH; HUMAN; MENOPAUSE; MOOD CHANGE; NAUSEA; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SCORING SYSTEM; SIDE EFFECT; SWEATING; BREAST TUMOR; CLINICAL TRIAL; ECONOMICS; FOLLOW UP; HOSPITALIZATION; MIDDLE AGED; PILOT STUDY;

ADULT; AGED; BREAST NEOPLASMS; DRUG COSTS; FEMALE; FOLLOW-UP STUDIES; HOT FLASHES; HUMANS; MAGNESIUM OXIDE; MEDICATION ADHERENCE; MENOPAUSE; MIDDLE AGED; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX;

EID: 80051671110     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-011-1099-7     Document Type: Article

References (17)

1. Feldman BM, Voda A, Gronseth E (1985) The prevalence of hot flash and associated variables among perimenopausal women. Res Nurs Health 8:261-268
2. Carpenter JS, Andrykowski MA (1999) Menopausal symptoms in breast cancer survivors. Oncol Nurs Forum 26:1311-1317
3. Loprinzi CL, Wolf SL, Barton DL et al (2008) Symptom management in premenopausal patients with breast cancer. Lancet Oncol 9:993-1001
4. Bordeleau L, Pritchard K, Goodwin P et al (2007) Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review. Clin Ther 29:230-241 (Pubitemid 46661858)
5. Quella SK, Loprinzi CL, Sloan JA et al (1998) Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes. Cancer 82:1784-1788 (Pubitemid 28208931)
6. Loprinzi CL, Levitt R, Barton D et al (2006) Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7. J Clin Oncol 24:1409-1414 (Pubitemid 46622006)
7. Smith TJ (2009) Magnesium supplements for menopausal hot flashes. J Clin Oncol 27:1151-1152
8. Houston MC, Harper KJ (2008) Potassium, magnesium, and calcium: their role in both the cause and treatment of hypertension. J Clin Hypertens (Greenwich) 10:3-11
9. Sibai BM (2003) Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102:181-192 (Pubitemid 36792143)
10. Gums JG (2004) Magnesium in cardiovascular and other disorders. Am J Health-Syst Pharm 61:1569-1576 (Pubitemid 39481397)
11. Nechifor M (2009) Magnesium in major depression. Magnes Res 22:163S-166S
12. Sloan JA, Loprinzi CL, Novotny PJ et al (2001) Methodologic lessons learned from hot flash studies. J Clin Oncol 19:4280-4290 (Pubitemid 33096775)
13. Mago R, Mahajan R, Thase ME (2008) Medically serious adverse effects of newer antidepressants. Curr Psychiatry Rep 10:249-257
14. Moret C, Isaac M, Briley M (2009) Problems associated with long-term treatment with selective serotonin reuptake inhibitors. J Psychopharmacol 23:967-974
15. Nechifor M (2008) Interactions between magnesium and psycho-tropic drugs. Magnes Res 21:97-100
16. Shanafelt TD, Barton DL, Adjei AA et al (2002) Pathophysiology and treatment of hot flashes. Mayo Clin Proc 77:1207-1218 (Pubitemid 35266369)
17. Kazaks AG, Uriu-Adams JY, Albertson TE et al (2010) Effect of oral magnesium supplementation on measures of airway resistance and subjective assessment of asthma control and quality of life in men and women with mild to moderate asthma: a randomized placebo controlled trial. J Asthma 47:83-92